Elekta AB (publ) - Asset Resilience Ratio

Latest as of January 2026: 9.18%

Elekta AB (publ) (EKTA-B) has an Asset Resilience Ratio of 9.18% as of January 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See EKTA-B working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr2.54 Billion
≈ $273.45 Million USD Cash + Short-term Investments

Total Assets

Skr27.68 Billion
≈ $2.98 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Elekta AB (publ)'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Elekta AB (publ) total assets.

Liquid Assets Composition Over Time

This chart breaks down Elekta AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Elekta AB (publ)'s assets are long-term investments to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr2.54 Billion 9.18%
Short-term Investments Skr0.00 0%
Total Liquid Assets Skr2.54 Billion 9.18%

Asset Resilience Insights

  • Limited Liquidity: Elekta AB (publ) maintains only 9.18% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Elekta AB (publ) Industry Peers by Asset Resilience Ratio

Compare Elekta AB (publ)'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
TransMedics Group Inc
NASDAQ:TMDX
Medical Devices 0.00%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Novocure Ltd
NASDAQ:NVCR
Medical Devices 43.72%
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581
Medical Devices 18.80%
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
Medical Devices 10.74%
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273
Medical Devices 34.29%

Annual Asset Resilience Ratio for Elekta AB (publ) (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Elekta AB (publ).

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-04-30 10.20% Skr2.96 Billion
≈ $318.01 Million
Skr28.98 Billion
≈ $3.12 Billion
+3.24pp
2024-04-30 6.96% Skr2.19 Billion
≈ $235.14 Million
Skr31.41 Billion
≈ $3.38 Billion
-0.64pp
2023-04-30 7.60% Skr2.25 Billion
≈ $242.14 Million
Skr29.61 Billion
≈ $3.19 Billion
-4.10pp
2022-04-30 11.70% Skr3.08 Billion
≈ $331.13 Million
Skr26.30 Billion
≈ $2.83 Billion
-1.07pp
2021-04-30 12.77% Skr3.17 Billion
≈ $341.36 Million
Skr24.84 Billion
≈ $2.67 Billion
-5.63pp
2020-04-30 18.40% Skr5.23 Billion
≈ $562.62 Million
Skr28.41 Billion
≈ $3.06 Billion
+8.42pp
2019-04-30 9.98% Skr2.40 Billion
≈ $258.49 Million
Skr24.06 Billion
≈ $2.59 Billion
+1.81pp
2018-04-30 8.17% Skr1.83 Billion
≈ $197.37 Million
Skr22.46 Billion
≈ $2.42 Billion
+2.09pp
2017-04-30 6.08% Skr1.27 Billion
≈ $137.00 Million
Skr20.95 Billion
≈ $2.25 Billion
+7.87pp
2016-04-30 -1.80% Skr-349.00 Million
≈ $-37.56 Million
Skr19.44 Billion
≈ $2.09 Billion
-0.12pp
2015-04-30 -1.67% Skr-354.00 Million
≈ $-38.10 Million
Skr21.18 Billion
≈ $2.28 Billion
-45.02pp
2012-04-30 43.35% Skr6.60 Billion
≈ $710.70 Million
Skr15.23 Billion
≈ $1.64 Billion
--
pp = percentage points

About Elekta AB (publ)

ST:EKTA-B Sweden Medical Devices
Market Cap
$2.06 Billion
Skr19.18 Billion SEK
Market Cap Rank
#6044 Global
#85 in Sweden
Share Price
Skr52.25
Change (1 day)
+4.40%
52-Week Range
Skr42.38 - Skr63.25
All Time High
Skr125.13
About

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa … Read more